Main content

    Cardiology Clinical Trials

    Heart Failure, LVAD & Heart Transplant ProgramOpens new window

    Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at ClinicalTrials.gov



    Title: Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction (AMI) Patients (VIRGO)
    Description: Examining Heart Attacks in Young Women (VIRGO)
    Investigator: Fiona Dulbecco, MD
    Eligibility: Subjects under the age of 56 who are hospitalized for a heart attack
    Status: Active but closed to enrollment
    Contact: Jessica Redford, RN, 415-600-1781, Email: RedforJ@cpmcri.org about Study VIRGO

    Title: The HeartMate II LVAS Pivotal Study Protocol, Destination Therapy
    Description: Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy
    Investigator: Ernest Haeusslein, MD
    Eligibility: Subjects with severe congestive heart failure who are not candidates for heart transplant
    Status: Active but closed to enrollment
    Contact: Jessica Redford, RN, 415-600-1781, Email: RedforJ@cpmcri.org about Study HeartMate

    Title: A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement
    Description: The Dual Antiplatelet Therapy Study (DAPT Study)
    Investigator: Sung Choi, MD
    Eligibility: Subjects >18 years of age undergoing percutaneous intervention with stent deployment
    Status: Active but closed to enrollment
    Contact: Jessica Redford, RN, 415-600-1781, Email: RedforJ@cpmcri.org about Study DAPT

    Title: A Prospective, Single-Blind, Randomized, Multi-Center Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE)
    Description: Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems
    Investigator: Bruce Brent, MD
    Eligibility: Pivotal Study for Subjects with de novo atherosclerotic CAD in 1 or 2 vessels
    Status: Active but closed to enrollment
    Contact: Jessica Redford, RN, 415-600-1781, Email: RedforJ@cpmcri.org about Study ELITE

    Title: Evaluation of the Safety and Efficacy of the OPTIMIZER System With Active Fixation Leads in Subjects With Heart Failure Resulting From Systolic Dysfunction: FIX-HF-5
    Description: Evaluation of the Safety and Effectiveness of the OPTIMIZER System in Subjects With Heart Failure: FIX-HF-5
    Investigator: Steven Hao, MD
    Eligibility: To evaluate the safety and effectiveness of the Optimizer III System with active fixation leads in subjects with moderate to severe heart failure.
    Status: Active but closed to enrollment
    Contact: Jessica Redford, RN, 415-600-1781, Email: RedforJ@cpmcri.org about Study OPTIMIZER

    • updated January 2012